Saturday, February 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

Empathy Gaps, Moral Hazards

Daily Remedy by Daily Remedy
August 27, 2022
in Uncertainty & Complexity
0
Empathy Gaps, Moral Hazards

We have many successful physicians. But we have few who do right by their patients. The dichotomy is jarring.

It appears because healthcare suffers from moral hazards. The perverse incentives are everywhere. We pretend to ignore them. So instead of moral hazards, we say moral injury, or find some clever catchphrase to belie the truth. We claim physicians are suffering because they are overworked. But physicians have been working fewer hours decade over decade since the 1970s – though the relative time a physician spends on non-clinical tasks is increasing.

So, to be a great physician today, you must prioritize the system of healthcare over the individual patient. This is the dichotomy.

A decade ago, a successful physician saw as many patients as possible throughout the day, but spent hardly any time with any one patient. Today, a successful physician is one who best documents the patient encounter, jotting every phrase or code necessary to maximize the financial reimbursement. As a result, physicians went from treating patients bedside to essaying the most elaborate patient notes.

These are the symptoms of a system rife with moral hazards. We see it throughout healthcare. For any proposed solution, we find an ulterior motive. These are the on-ground realities of a healthcare system laced with questionable incentives. When hospitals began incurring penalties for readmissions, hospital leaders began changing the readmitting diagnoses.

No proposed solution, whether it is to improve outcomes or reduce costs, can work until we fix the moral hazard problem. It emerged when we transformed clinical medicine into a healthcare system. Out of that complexity formed a matrix of incentives. None of which are alone wrong, but when combined, produce recurring patterns of moral hazards.

Leaders in healthcare no longer respond to the intended effect of any policy. They react to the implicit moral hazards within it. While we may never find an exact solution, we can at least begin to address the matter with effective leadership.

Right now, these leaders lack the ability to guide because they have lost touch with the individual patient. We put too many degrees of separation between patients and health leaders.

The moral hazards appear within the separation. It explains why healthcare leaders prioritize reducing length of stay with little regard to the individual patient experience; why patients discharged with congestive heart failure suddenly get readmitted with acute respiratory distress. The leaders never see the patient; they only see the data points, and by proxy, the financials.

Data never convey empathy, so health leaders remain blind to it. They never see how financial decisions affect the patient experience. This underlies the network of moral hazards.

When we separate cause and effect, people lose sight of the consequences of their actions. Clinical decisions are not burdened by the weight of the outcomes. And without such anchoring, we lose sight of why we care for patients.

The solution, or at least the start to it, is not difficult: Fill the empathy gap by connecting cause and effect. Ensure patients and healthcare leaders interact over more than data-driven cash flow statements. A leader who sees the faces of patients affected by his or her policy will make decisions quite differently from someone who only sees the metrics.

Empathy is funny like that. We never notice it until it is long gone. Only then does it become apparent by what appears in its absence. As healthcare grew, it became more complicated. Eventually, it grew beyond the comprehension of any one person. This is when medicine became a healthcare system: a necessary change to accommodate the growing patient population and the influx of technology into medical care.

But now the system has grown beyond recognition. The incentives designed to make healthcare more efficient have created undue separations, disconnecting parts that were never meant to be split.

Within these crevices emerged the moral hazards, creating empathy gaps to fill the void.

It is time we acknowledge them in healthcare. So we may study the effects of empathy on patient care. Hopefully, we learn that it is more than an emotion derived from experience; it is the essence of good clinical care.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • Tapping Into the Mind Body Connection

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy